BR0214208A - Composições farmacêuticas e cosméticas que contêm aldeìdos aromáticos que suportam grupos de oxigênio - Google Patents
Composições farmacêuticas e cosméticas que contêm aldeìdos aromáticos que suportam grupos de oxigênioInfo
- Publication number
- BR0214208A BR0214208A BR0214208-2A BR0214208A BR0214208A BR 0214208 A BR0214208 A BR 0214208A BR 0214208 A BR0214208 A BR 0214208A BR 0214208 A BR0214208 A BR 0214208A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical
- compositions containing
- cosmetic compositions
- containing aromatic
- aromatic aldehydes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
"COMPOSIçõES FARMACêUTICAS E COSMéTICAS QUE CONTêM ALDEìDOS AROMáTICOS QUE SUPORTAM GRUPOS DE OXIGêNIO". São apresentadas composições farmacêuticas e cosméticas que contêm compostos de aldeídos aromáticos que suportam grupos de oxigênio ou seus derivados acetais. Algumas das composições apresentadas são úteis como terapêuticos tópicos para tratar condições dermatológicas inflamatórias. Algumas das composições são úteis em formas transdérmicas e outras formas de doses sistêmicas para tratar outras condições inflamatórias em mamíferos.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33227701P | 2001-11-16 | 2001-11-16 | |
US34604902P | 2002-01-04 | 2002-01-04 | |
US36851802P | 2002-04-01 | 2002-04-01 | |
US36856502P | 2002-04-01 | 2002-04-01 | |
US38469002P | 2002-05-30 | 2002-05-30 | |
US38458902P | 2002-05-30 | 2002-05-30 | |
PCT/US2002/021844 WO2003043621A1 (en) | 2001-11-16 | 2002-08-16 | Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0214208A true BR0214208A (pt) | 2004-10-26 |
Family
ID=32660228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0214208-2A BR0214208A (pt) | 2001-11-16 | 2002-08-16 | Composições farmacêuticas e cosméticas que contêm aldeìdos aromáticos que suportam grupos de oxigênio |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1443915B1 (pt) |
JP (2) | JP4587669B2 (pt) |
KR (1) | KR100887601B1 (pt) |
CN (2) | CN102973417A (pt) |
AT (1) | ATE330591T1 (pt) |
AU (1) | AU2002326363B2 (pt) |
BR (1) | BR0214208A (pt) |
CA (1) | CA2464867C (pt) |
DE (1) | DE60212683T2 (pt) |
DK (1) | DK1443915T3 (pt) |
EA (1) | EA009281B1 (pt) |
ES (1) | ES2266554T3 (pt) |
IL (2) | IL161545A0 (pt) |
MX (1) | MXPA04004673A (pt) |
NZ (1) | NZ552216A (pt) |
PT (1) | PT1443915E (pt) |
TW (1) | TWI297604B (pt) |
WO (1) | WO2003043621A1 (pt) |
ZA (1) | ZA200403282B (pt) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8246969B2 (en) | 2001-11-16 | 2012-08-21 | Skinmedica, Inc. | Compositions containing aromatic aldehydes and their use in treatments |
WO2004103233A1 (en) * | 2003-05-15 | 2004-12-02 | Cutanix Corporation | Compositions containing a combination of a pharmaceutical agent or a cosmetic agent and an oxy group-bearing aromatic aldehyde |
US8785403B2 (en) | 2003-08-01 | 2014-07-22 | Mitsubishi Tanabe Pharma Corporation | Glucopyranoside compound |
PL1651658T5 (pl) | 2003-08-01 | 2020-11-30 | Mitsubishi Tanabe Pharma Corporation | Nowe związki o działaniu inhibitującym transporter zależny od sodu |
TW200526678A (en) | 2003-08-01 | 2005-08-16 | Janssen Pharmaceutica Nv | Substituted indole-O-glucosides |
WO2007002447A2 (en) * | 2005-06-23 | 2007-01-04 | Bioform Medical, Inc. | Compositions for treating rosacea |
GB0526283D0 (en) * | 2005-12-23 | 2006-02-01 | Givaudan Sa | Compositions |
UY30730A1 (es) | 2006-12-04 | 2008-07-03 | Mitsubishi Tanabe Pharma Corp | Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno |
KR101552187B1 (ko) | 2007-09-10 | 2015-09-10 | 얀센 파마슈티카 엔.브이. | Sglt 억제제로서 유용한 화합물의 제조 방법 |
US9616006B2 (en) | 2007-10-10 | 2017-04-11 | DermaMedics, LLC | Methods and compositions for treating dermatological diseases and conditions |
EP3238696A1 (en) * | 2007-10-10 | 2017-11-01 | Therametics, Llc | Methods and compositions for treating dermatological diseases and conditions |
CL2008003653A1 (es) | 2008-01-17 | 2010-03-05 | Mitsubishi Tanabe Pharma Corp | Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica. |
US9056850B2 (en) | 2008-10-17 | 2015-06-16 | Janssen Pharmaceutica N.V. | Process for the preparation of compounds useful as inhibitors of SGLT |
US20110009347A1 (en) | 2009-07-08 | 2011-01-13 | Yin Liang | Combination therapy for the treatment of diabetes |
EA024368B1 (ru) | 2009-10-14 | 2016-09-30 | Янссен Фармацевтика Нв | Процесс получения соединений для применения в качестве ингибиторов sglt2 |
JP6227406B2 (ja) | 2010-05-11 | 2017-11-08 | ヤンセン ファーマシューティカ エヌ.ベー. | SGLTの阻害剤としての1−(β−D−グルコピラノシル)−2−チエニル−メチルベンゼン誘導体を含有する医薬製剤 |
EP2661264B1 (en) * | 2011-01-07 | 2018-12-05 | Allergan, Inc. | Melanin modification compositions and methods of use |
CA2832938C (en) | 2011-04-13 | 2019-09-03 | Janssen Pharmaceutica Nv | Process for the preparation of compounds useful as inhibitors of sglt2 |
US9035044B2 (en) | 2011-05-09 | 2015-05-19 | Janssen Pharmaceutica Nv | L-proline and citric acid co-crystals of (2S, 3R, 4R, 5S,6R)-2-(3-((5-(4-fluorophenyl)thiopen-2-yl)methyl)4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
JP6061373B2 (ja) * | 2012-07-24 | 2017-01-18 | 国立研究開発法人産業技術総合研究所 | 2−ヒドロキシベンズアルデヒド化合物、これを含有するコラーゲン細胞外分泌阻害剤及び医薬品組成物 |
CN104473912A (zh) * | 2014-11-26 | 2015-04-01 | 云南中医学院 | 对羟基苯甲醛在制备抗炎药物中的用途 |
US20170071970A1 (en) | 2015-09-15 | 2017-03-16 | Janssen Pharmaceutica Nv | Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders |
JP2019116426A (ja) * | 2017-12-26 | 2019-07-18 | 小林製薬株式会社 | 歯肉組織の破壊抑制剤 |
FR3081710A1 (fr) * | 2018-05-31 | 2019-12-06 | Bionuclei | Molecule enzymatique mimant une activite antioxydante |
GB201817785D0 (en) * | 2018-10-31 | 2018-12-19 | Givaudan Sa | Organic compounds |
WO2022128054A1 (en) * | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for fighting inflammatory conditions of human skin (iv) |
WO2022128051A1 (en) * | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for fighting inflammatory conditions of human skin (ii) |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US414770A (en) * | 1889-11-12 | Swaging-bench for iron fences | ||
JPS5244375B2 (pt) * | 1974-04-19 | 1977-11-08 | ||
DE2519161A1 (de) * | 1975-04-30 | 1976-11-18 | Henkel & Cie Gmbh | Entzuendungshemmer fuer kosmetische praeparationen |
JPS604801B2 (ja) * | 1977-11-21 | 1985-02-06 | 呉羽化学工業株式会社 | 抗皮膚真菌剤 |
JPS5545656A (en) * | 1978-09-28 | 1980-03-31 | Rikagaku Kenkyusho | Carcinostatic agent |
JPS5545659A (en) * | 1978-09-28 | 1980-03-31 | Rikagaku Kenkyusho | Carcinostatic agent |
JPS5612310A (en) * | 1979-07-10 | 1981-02-06 | Rikagaku Kenkyusho | Carcinostatic agent |
GB8501646D0 (en) * | 1985-01-23 | 1985-02-27 | Nipa Lab Ltd | Control of micro-organisms |
US4714609A (en) * | 1986-07-21 | 1987-12-22 | Laverne Stanley | Skin tanning composition |
JPH085780B2 (ja) * | 1989-04-28 | 1996-01-24 | 呉羽化学工業株式会社 | 変形性関節症治療剤 |
CA2017923A1 (en) * | 1989-06-06 | 1990-12-06 | Gordon Francis Brunner | Heated oral antitussive compositions |
GB9026080D0 (en) * | 1990-11-30 | 1991-01-16 | Norsk Hydro As | Pharmaceutical compositions |
JP3057207B2 (ja) * | 1991-09-03 | 2000-06-26 | 株式会社資生堂 | 皮膚外用剤 |
US5378468A (en) * | 1992-09-22 | 1995-01-03 | The Mennen Company | Composition containing body activated fragrance for contacting the skin and method of use |
JPH072640A (ja) * | 1992-10-29 | 1995-01-06 | Marino Forum 21 | 紫外線障害防御外用剤 |
JPH06329516A (ja) * | 1993-05-21 | 1994-11-29 | Mikimoto Pharmaceut Co Ltd | 化粧料 |
GB9314929D0 (en) * | 1993-07-19 | 1993-09-01 | Charwell Consumer Prod | Louse repellent compositions |
JPH07242558A (ja) * | 1994-03-05 | 1995-09-19 | Tomoji Tanaka | 床ズレ防止剤添加体 |
JP3665360B2 (ja) * | 1994-05-02 | 2005-06-29 | ポーラ化成工業株式会社 | 活性酸素消去剤及びこれを含む組成物 |
US5614179A (en) * | 1995-09-27 | 1997-03-25 | Church & Dwight Co., Inc. | Cosmetic deodorant products containing a polymer/fragrance-encapsulated bicarbonate ingredient |
US5733535A (en) * | 1995-10-25 | 1998-03-31 | The Procter & Gamble Co. | Topical compositions containing N-acetylcysteine and odor masking materials |
US6086903A (en) * | 1996-02-26 | 2000-07-11 | The Proctor & Gamble Company | Personal treatment compositions and/or cosmetic compositions containing enduring perfume |
US5766575A (en) * | 1996-06-14 | 1998-06-16 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Method and composition for skin lightening |
US5668182A (en) * | 1996-08-19 | 1997-09-16 | Virginia Commonwealth University | Method of calming or sedating an animal with a hydroxy benzaldehyde compound |
US6126930A (en) * | 1997-02-13 | 2000-10-03 | The Procter & Gamble Company | Spray compositions |
US6204229B1 (en) * | 1997-03-18 | 2001-03-20 | Kao Corporation | Composition to be applied to hair or skin |
US6214879B1 (en) * | 1998-03-24 | 2001-04-10 | Virginia Commonwealth University | Allosteric inhibitors of pyruvate kinase |
DE19841796A1 (de) * | 1998-09-12 | 2000-03-16 | Beiersdorf Ag | Kombinationen von Antiadhäsiva (Kohlenhydrate) und Mikrobiziden |
JP2001106639A (ja) * | 1999-10-04 | 2001-04-17 | Taisho Pharmaceut Co Ltd | 経口用組成物 |
-
2002
- 2002-08-16 CA CA2464867A patent/CA2464867C/en not_active Expired - Lifetime
- 2002-08-16 DK DK02761067T patent/DK1443915T3/da active
- 2002-08-16 WO PCT/US2002/021844 patent/WO2003043621A1/en active IP Right Grant
- 2002-08-16 EA EA200400689A patent/EA009281B1/ru unknown
- 2002-08-16 BR BR0214208-2A patent/BR0214208A/pt not_active IP Right Cessation
- 2002-08-16 MX MXPA04004673A patent/MXPA04004673A/es active IP Right Grant
- 2002-08-16 JP JP2003545302A patent/JP4587669B2/ja not_active Expired - Lifetime
- 2002-08-16 AU AU2002326363A patent/AU2002326363B2/en not_active Expired
- 2002-08-16 EP EP02761067A patent/EP1443915B1/en not_active Expired - Lifetime
- 2002-08-16 CN CN2012102290813A patent/CN102973417A/zh active Pending
- 2002-08-16 ES ES02761067T patent/ES2266554T3/es not_active Expired - Lifetime
- 2002-08-16 AT AT02761067T patent/ATE330591T1/de active
- 2002-08-16 NZ NZ552216A patent/NZ552216A/en not_active IP Right Cessation
- 2002-08-16 DE DE60212683T patent/DE60212683T2/de not_active Expired - Lifetime
- 2002-08-16 PT PT02761067T patent/PT1443915E/pt unknown
- 2002-08-16 CN CNA028227166A patent/CN1589136A/zh active Pending
- 2002-08-16 KR KR1020047007429A patent/KR100887601B1/ko active IP Right Grant
- 2002-08-16 IL IL16154502A patent/IL161545A0/xx unknown
- 2002-10-31 TW TW091132250A patent/TWI297604B/zh not_active IP Right Cessation
-
2004
- 2004-04-21 IL IL161545A patent/IL161545A/en active IP Right Grant
- 2004-04-30 ZA ZA200403282A patent/ZA200403282B/en unknown
-
2009
- 2009-12-11 JP JP2009282263A patent/JP2010059203A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU2002326363A1 (en) | 2003-06-10 |
EA200400689A1 (ru) | 2005-02-24 |
NZ552216A (en) | 2008-07-31 |
CA2464867A1 (en) | 2003-05-30 |
JP2005509662A (ja) | 2005-04-14 |
IL161545A0 (en) | 2004-09-27 |
CA2464867C (en) | 2014-01-28 |
KR100887601B1 (ko) | 2009-03-13 |
EP1443915B1 (en) | 2006-06-21 |
MXPA04004673A (es) | 2005-05-17 |
TW200406195A (en) | 2004-05-01 |
JP2010059203A (ja) | 2010-03-18 |
CN1589136A (zh) | 2005-03-02 |
JP4587669B2 (ja) | 2010-11-24 |
DE60212683D1 (de) | 2006-08-03 |
DE60212683T2 (de) | 2007-06-28 |
ZA200403282B (en) | 2005-05-03 |
WO2003043621A1 (en) | 2003-05-30 |
AU2002326363B2 (en) | 2008-08-28 |
TWI297604B (en) | 2008-06-11 |
ES2266554T3 (es) | 2007-03-01 |
PT1443915E (pt) | 2006-11-30 |
DK1443915T3 (da) | 2006-10-23 |
IL161545A (en) | 2010-11-30 |
ATE330591T1 (de) | 2006-07-15 |
EP1443915A1 (en) | 2004-08-11 |
KR20050018633A (ko) | 2005-02-23 |
EA009281B1 (ru) | 2007-12-28 |
CN102973417A (zh) | 2013-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0214208A (pt) | Composições farmacêuticas e cosméticas que contêm aldeìdos aromáticos que suportam grupos de oxigênio | |
BRPI0207961A8 (pt) | Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos. | |
PT1117440E (pt) | Composicoes farmaceuticas que contem paclitaxel | |
ATE478664T1 (de) | Azaphenanthridone-derivate und deren verwendung als parp-inhibitoren | |
MA28102A1 (fr) | Formulations pharmaceutiques, methodes et schemas d'administration pour le traitement et la prevention des syndromes coronariens aigus | |
DK0752898T3 (da) | Mindskning af hudirritation ved elektrotransport-tilførsel | |
BRPI0110371B8 (pt) | inibidores de fosfatidilinositol 3-cinase delta humana | |
NO20052446L (no) | Anvendelse av idebenone ved fremstilling av medikament | |
BRPI0307550B8 (pt) | composição farmacêutica em gel tópica, de adapaleno 0,3% | |
NO20032254L (no) | Forbindelser for inhibering av ekspresjon av VACM-I | |
NO20052494L (no) | Preparater inneholdende melatonin, gingko biloba og biotin. | |
ATE412417T1 (de) | Topische zusammensetzung zur behandlung von psoriasis und verwandten hautkrankheiten | |
EE04056B1 (et) | Piperasiini derivaadid ja nende kasutamine põletikuvastaste vahenditena | |
BR0013935A (pt) | IsÈmeros oticamente ativos de cetotifeno e metabólitos terapeuticamente ativos dos mesmos | |
BR9810520A (pt) | Inibidor do fator xa isolado ou em combinação com um anti-agregador plaquetário, contra a trambose arterial | |
IS6439A (is) | Samsetningar til að meðhöndla viðnám gegn háþrýstingslyfjum | |
BR0307518A (pt) | Composição farmacêutica | |
CA2441461A1 (en) | Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia | |
NO20064753L (no) | Kombinasjonsterapi | |
DK0991424T3 (da) | Farmaceutiske præparater omfattende en inhibitor for aldosereduktase og en inhibitor for ACE | |
ES2120667T3 (es) | Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para tratamiento de dermatosis. | |
BR0009194A (pt) | Composição do resorcinol | |
ATE393624T1 (de) | Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs | |
ATE240100T1 (de) | Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten | |
IT1320192B1 (it) | Composizione terapeutica per la cura della psoriasi. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: CONFORME ARTIGO 10O DA RESOLUCAO 124/06, CABE SER ARQUIVADO REFERENTE AO NAO RECOLHIMENTO DA 9A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2138 DE 27/12/2011 E CONSIDERANDO A AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS. INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE. |
|
B25B | Requested transfer of rights rejected |
Owner name: CUTANIX CORPORATION (US) |
|
B25E | Requested change of name of applicant rejected |
Owner name: CUTANIX CORPORATION (US) |
|
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 8/33 (2006.01), A61K 8/34 (2006.01), A61K 9/0 |